(TDIV) VanEck Morningstar - Ratings and Ratios
Dividend, Paying, Stocks, Global, Equities, High, Yield
Description: TDIV VanEck Morningstar
The VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF CHF, ticker symbol TDIV, is a Global Equity Income ETF that tracks the Morningstar Global High Dividend Yield Index. This ETF is designed to provide investors with exposure to a diversified portfolio of high-dividend-yielding stocks from developed markets.
The ETFs underlying index is constructed to represent the performance of companies that have a history of paying consistent dividends, and are expected to continue doing so. By focusing on dividend leaders, the ETF aims to provide a relatively stable source of income for investors, while also offering the potential for long-term capital appreciation.
Analyzing the ETFs recent price action, we can see that it has been trending upwards, with its short-term moving averages (SMA20 and SMA50) indicating a positive momentum. The current price of 40.07 is above its SMA20 and SMA50, suggesting a continued upward trend. Furthermore, the Average True Range (ATR) of 0.46, representing a 1.16% daily volatility, indicates a relatively stable price movement.
Using the available technical and fundamental data, we can forecast that the ETF is likely to continue its upward trend, driven by its underlying dividend-yielding stocks. With an Assets Under Management (AUM) of 1912.24M CHF, the ETF has a significant presence in the market, which could contribute to its liquidity and stability. Based on the current SMA20 and SMA50, we can expect the ETFs price to potentially reach 41.50 in the short term, representing a 3.5% increase from its current price. However, its essential to monitor the ETFs performance and adjust the forecast accordingly, as market conditions can change rapidly.
In conclusion, the VanEck Morningstar Developed Markets Dividend Leaders UCITS ETF CHF (TDIV) is a viable investment option for those seeking exposure to high-dividend-yielding stocks from developed markets. Its diversified portfolio and relatively stable price movement make it an attractive choice for income-seeking investors. However, its crucial to continually evaluate the ETFs performance and adjust investment decisions accordingly.
Additional Sources for TDIV ETF
TDIV ETF Overview
Market Cap in USD | 2,411m |
Category | Global Equity Income |
TER | 0.38% |
IPO / Inception | 2016-05-23 |
TDIV ETF Ratings
Growth Rating | 69.4 |
Fundamental | - |
Dividend Rating | 59.3 |
Rel. Strength | -2.53 |
Analysts | - |
Fair Price Momentum | 41.25 CHF |
Fair Price DCF | - |
TDIV Dividends
Dividend Yield 12m | 3.86% |
Yield on Cost 5y | 7.31% |
Annual Growth 5y | 6.37% |
Payout Consistency | 95.9% |
Payout Ratio | % |
TDIV Growth Ratios
Growth Correlation 3m | 56% |
Growth Correlation 12m | 80% |
Growth Correlation 5y | 92.1% |
CAGR 5y | 25.93% |
CAGR/Max DD 5y | 1.43 |
Sharpe Ratio 12m | 1.37 |
Alpha | 4.14 |
Beta | 0.467 |
Volatility | 11.81% |
Current Volume | 1.6k |
Average Volume 20d | 2.5k |
Stop Loss | 38.2 (-3.5%) |
As of July 12, 2025, the stock is trading at CHF 39.60 with a total of 1,552 shares traded.
Over the past week, the price has changed by +0.32%, over one month by -1.61%, over three months by +13.35% and over the past year by +11.03%.
Yes. Based on ValueRay's Analyses, VanEck Morningstar (SW:TDIV) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 69.39 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of TDIV is around 41.25 CHF . This means that TDIV is currently overvalued and has a potential downside of 4.17%.
VanEck Morningstar has no consensus analysts rating.
According to our own proprietary Forecast Model, TDIV VanEck Morningstar will be worth about 46.2 in July 2026. The stock is currently trading at 39.60. This means that the stock has a potential upside of +16.62%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 46.2 | 16.6% |